Nykredit A S purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 170,509 shares of the financial services provider's stock, valued at approximately $28,419,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. EP Wealth Advisors LLC boosted its holdings in shares of Marsh & McLennan Companies by 0.8% in the second quarter. EP Wealth Advisors LLC now owns 8,337 shares of the financial services provider's stock worth $1,823,000 after acquiring an additional 69 shares during the period. Continuum Advisory LLC lifted its holdings in Marsh & McLennan Companies by 5.3% during the 1st quarter. Continuum Advisory LLC now owns 1,452 shares of the financial services provider's stock worth $252,000 after purchasing an additional 73 shares in the last quarter. Clearstead Trust LLC boosted its stake in Marsh & McLennan Companies by 12.6% in the 1st quarter. Clearstead Trust LLC now owns 668 shares of the financial services provider's stock worth $116,000 after purchasing an additional 75 shares during the period. GRIMES & Co WEALTH MANAGEMENT LLC grew its holdings in Marsh & McLennan Companies by 0.9% during the 4th quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 8,883 shares of the financial services provider's stock valued at $1,648,000 after buying an additional 79 shares in the last quarter. Finally, Boyd Watterson Asset Management LLC OH increased its position in shares of Marsh & McLennan Companies by 1.2% during the fourth quarter. Boyd Watterson Asset Management LLC OH now owns 6,791 shares of the financial services provider's stock valued at $1,260,000 after buying an additional 80 shares during the period. Institutional investors own 87.99% of the company's stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies stock opened at $188.42 on Friday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $207.82. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.14 and a current ratio of 1.14. The stock has a market cap of $89.92 billion, a PE ratio of 23.03, a P/E/G ratio of 2.61 and a beta of 0.58. The firm's fifty day moving average is $184.77.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The company had revenue of $7.28 billion during the quarter. The company's revenue was up 6.2% compared to the same quarter last year. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current year.
Marsh & McLennan Companies Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd were given a dividend of $0.99 per share. This is a boost from Marsh & McLennan Companies's previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. This represents a $3.96 annualized dividend and a dividend yield of 2.1%. Marsh & McLennan Companies's dividend payout ratio is currently 48.41%.
Wall Street Analysts Forecast Growth
MRSH has been the topic of a number of analyst reports. Weiss Ratings raised shares of Marsh & McLennan Companies from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, August 7th. Mizuho boosted their price target on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the company a "neutral" rating in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. lifted their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Piper Sandler decreased their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 26th. Finally, Morgan Stanley raised their price target on Marsh & McLennan Companies from $180.00 to $200.00 and gave the company an "equal weight" rating in a report on Wednesday, August 19th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Marsh & McLennan Companies presently has a consensus rating of "Hold" and an average price target of $203.50.
Read Our Latest Report on MRSH
Insider Activity at Marsh & McLennan Companies
In related news, insider Martin South sold 7,100 shares of the business's stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares in the company, valued at $3,159,913.68. The trade was a 29.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Lloyd Yates sold 12,000 shares of the company's stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the completion of the sale, the director directly owned 12,001 shares of the company's stock, valued at approximately $2,107,975.65. This represents a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 19,813 shares of company stock valued at $3,597,903. Corporate insiders own 0.38% of the company's stock.
About Marsh & McLennan Companies
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report